CGON
Price
$27.11
Change
+$0.07 (+0.26%)
Updated
Jul 10 closing price
Capitalization
2.06B
27 days until earnings call
PROK
Price
$5.18
Change
+$0.84 (+19.35%)
Updated
Jul 10 closing price
Capitalization
562.19M
27 days until earnings call
Interact to see
Advertisement

CGON vs PROK

Header iconCGON vs PROK Comparison
Open Charts CGON vs PROKBanner chart's image
CG Oncology
Price$27.11
Change+$0.07 (+0.26%)
Volume$526.27K
Capitalization2.06B
ProKidney
Price$5.18
Change+$0.84 (+19.35%)
Volume$73.42M
Capitalization562.19M
CGON vs PROK Comparison Chart in %
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. PROK commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Buy and PROK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (CGON: $27.11 vs. PROK: $5.18)
Brand notoriety: CGON and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 50% vs. PROK: 487%
Market capitalization -- CGON: $2.06B vs. PROK: $562.19M
CGON [@Biotechnology] is valued at $2.06B. PROK’s [@Biotechnology] market capitalization is $562.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, both CGON and PROK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 3 TA indicator(s) are bullish while PROK’s TA Score has 7 bullish TA indicator(s).

  • CGON’s TA Score: 3 bullish, 3 bearish.
  • PROK’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, PROK is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а +0.78% price change this week, while PROK (@Biotechnology) price change was +712.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

CGON is expected to report earnings on Aug 07, 2025.

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($2.06B) has a higher market cap than PROK($562M). PROK YTD gains are higher at: 206.509 vs. CGON (-5.474). CGON has higher annual earnings (EBITDA): -134.35M vs. PROK (-160.12M). CGON has more cash in the bank: 688M vs. PROK (328M). CGON has less debt than PROK: CGON (1.04M) vs PROK (3.37M). CGON has higher revenues than PROK: CGON (662K) vs PROK (306K).
CGONPROKCGON / PROK
Capitalization2.06B562M367%
EBITDA-134.35M-160.12M84%
Gain YTD-5.474206.509-3%
P/E RatioN/AN/A-
Revenue662K306K216%
Total Cash688M328M210%
Total Debt1.04M3.37M31%
TECHNICAL ANALYSIS
Technical Analysis
CGONPROK
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
61%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 10 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
70%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCYIX47.65N/A
N/A
Fidelity Select Industrials Portfolio
LSSIX28.99N/A
N/A
Loomis Sayles Small Cap Growth Instl
QMGRX12.41N/A
N/A
Invesco Advantage International R
OGFAX94.03N/A
N/A
JPMorgan Equity Index R6
TRCSX15.91N/A
N/A
T. Rowe Price Small-Cap Index I

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+0.26%
IDYA - CGON
60%
Loosely correlated
-0.74%
SYRE - CGON
58%
Loosely correlated
-3.56%
ACLX - CGON
58%
Loosely correlated
-0.20%
NUVL - CGON
56%
Loosely correlated
+0.70%
KRYS - CGON
55%
Loosely correlated
+0.56%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with NRIX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+19.35%
NRIX - PROK
39%
Loosely correlated
-3.87%
CGON - PROK
39%
Loosely correlated
+0.26%
APGE - PROK
38%
Loosely correlated
+4.19%
CGEM - PROK
37%
Loosely correlated
+0.51%
KYMR - PROK
37%
Loosely correlated
+0.07%
More